Gland Pharma Limited (BOM:543245)
India · Delayed Price · Currency is INR 2,479.70
+10.65 (0.43%)
At close: Jul 10, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 405.5 billion as of July 13, 2026. Its market cap has increased by 44.17% in one year.
Market Cap
405.50B
Enterprise Value
374.01B
Revenue
64.31B
Ranking
n/a
PE Ratio
39.47
Stock Price
2,479.70
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 405.50B, an increase of 36.48%. That is a compound annual growth rate of 5.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 408.50B | 43.98% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.14T |
| Dr. Reddy's Laboratories | 1.04T |
| Abbott India | 576.39B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 235.82B |
| Granules India | 220.43B |
| AstraZeneca Pharma India | 203.10B |